Standard BioTools Announces Conference Call and Webcast for Third Quarter 2024 Financial Results on October 30, 2024
LAB Stock | USD 1.84 0.02 1.10% |
About 74 percent of all Standard Biotools' investors are curious in acquiring. The analysis of overall sentiment of trading Standard Biotools stock suggests that quite a large number of investors are confidant at this time. The current market sentiment, together with Standard Biotools' historical and current headlines, can help investors time the market. In addition, many technical investors use Standard Biotools stock news signals to limit their universe of possible portfolio assets.
Standard |
SOUTH SAN FRANCISCO, Calif., Oct. 16, 2024 -- Standard BioTools Inc. today announced that it will report third quarter 2024 financial results on Wednesday, October 30, 2024, after the close of the market. The Companys management will host a conference call and webcast at 130 p.m. PT, 430 p.m. ET, on October 30, 2024, to discuss third quarter 2024 financial results and operational progress. A press release including the financial results will be publicly distribu
Read at finance.yahoo.com
Standard Biotools Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Standard Biotools can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Standard Biotools Fundamental Analysis
We analyze Standard Biotools' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Standard Biotools using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Standard Biotools based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
EBITDA
EBITDA Comparative Analysis
Standard Biotools is currently under evaluation in ebitda category among its peers. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Standard Biotools Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Standard Biotools stock to make a market-neutral strategy. Peer analysis of Standard Biotools could also be used in its relative valuation, which is a method of valuing Standard Biotools by comparing valuation metrics with similar companies.
Peers
Standard Biotools Related Equities
BNR | Burning Rock | 16.01 | ||||
DRIO | DarioHealth Corp | 9.72 | ||||
STIM | Neuronetics | 4.17 | ||||
NOTV | Inotiv | 3.39 | ||||
STRRP | Star Equity | 2.73 | ||||
MDXH | MDxHealth | 2.04 | ||||
SERA | Sera Prognostics | 1.81 | ||||
BDSX | Biodesix | 0.70 | ||||
FONR | Fonar | 0.49 | ||||
NDRA | ENDRA Life | 5.62 |
Complementary Tools for Standard Stock analysis
When running Standard Biotools' price analysis, check to measure Standard Biotools' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Standard Biotools is operating at the current time. Most of Standard Biotools' value examination focuses on studying past and present price action to predict the probability of Standard Biotools' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Standard Biotools' price. Additionally, you may evaluate how the addition of Standard Biotools to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
CEOs Directory Screen CEOs from public companies around the world | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |